JP Morgan Chase’s Bio-Techne TECH Stock Holding History

JP Morgan Chase’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-130,000	Closed	-$9.31M	–	7672
2024 Q2	$9.31M	Buy	+130,000	New	+$9.57M	﹤0.01%	2524

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase's TECH Position: Q2 2026 in Review

JP Morgan Chase increased its Bio-Techne (TECH) stake by 82% in Q2 2026, buying an estimated $45.2M and bringing the position to 1,862,805 shares worth $133M. The position accounts for 0.01% of the portfolio, ranked #928.

JP Morgan Chase first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

JP Morgan Chase held 1,862,805 shares of Bio-Techne worth $133M as of Q2 2026.
JP Morgan Chase bought 837,700 Bio-Techne shares in Q2 2026, an estimated $45.2M.
Bio-Techne made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #928 holding.
JP Morgan Chase first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.